Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanoma.
about
Single-cell technologies to study the immune systemAdoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlookAdvances in the treatment of metastatic melanoma: adoptive T-cell therapyDistribution, persistence, and efficacy of adoptively transferred central and effector memory-derived autologous simian immunodeficiency virus-specific CD8+ T cell clones in rhesus macaques during acute infection.Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy.Th cells promote CTL survival and memory via acquired pMHC-I and endogenous IL-2 and CD40L signaling and by modulating apoptosis-controlling pathways.Hedgehog/GLI signaling activates suppressor of cytokine signaling 1 (SOCS1) in epidermal and neural tumor cellsAdoptive cell therapy for the treatment of patients with metastatic melanoma.Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length.Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials.The tumor microenvironment and its role in promoting tumor growth.CD8+ T cell efficacy in vaccination and disease.A new approach to simultaneously quantify both TCR α- and β-chain diversity after adoptive immunotherapyAnalysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican‑3‑derived peptideAdvances in the development of cancer immunotherapies.Adoptive T-cell transfer in melanoma.Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells.Characterization of T-cell memory phenotype after in vitro expansion of tumor-infiltrating lymphocytes from melanoma patients.Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model.A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days.Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT.T Cell Receptor Profiling in Type 1 Diabetes.Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients.Delivery of mengovirus-derived RNA replicons into tumoural liver enhances the anti-tumour efficacy of a peripheral peptide-based vaccine.Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8+ T cells in patients with myeloid malignancies.Biased usage of T cell receptor β-chain variable region genes of Wilms' tumor gene (WT1)-specific CD8+ T cells in patients with solid tumors and healthy donors.Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer.Advances and Prospects in Cancer Immunotherapy
P2860
Q26778375-C0FC08B1-F891-4104-ADE1-6956EE2AF70BQ27004178-A177229C-4682-404C-AAD8-44853A05A13FQ27027803-92459709-8CEE-42D8-825C-74CF6C835456Q33554940-B82AFCB9-ACE1-4068-9F01-BDD05034EFF9Q34314036-C97FCAB5-FB77-4BF8-B962-E0302E7B6F78Q34778623-E765B3F6-AE5D-46FC-92B3-F017A1E6E2D1Q34995035-67A3BB34-7CAD-4A50-A53C-DFB1B096E676Q36283034-1D90D776-C946-4C5D-925F-79FE8B6124E3Q36294809-8B3B0C19-EC0B-4722-A121-811004FF2A84Q36453570-D59C6885-522A-4AA1-9CAD-4C996C6E1B38Q36946019-3EC16795-5733-4D5B-8BF0-C1AB2BB28C2EQ37184070-73EB6397-8AC9-4AC4-B993-F16D06C2811AQ37296033-916150DC-9C1B-491C-9B86-01020C285D01Q37313380-5A373419-52B7-401F-8B18-222A0DD6EDA4Q38049010-D783A76B-67CB-42B0-A3A6-E49FFB13B32EQ38068968-FC63CEFE-915B-4848-9132-947EA4F7297EQ38170500-62E09191-9E5B-4CA3-8C0E-B744EAC23128Q39133222-FE7E1598-8D73-42F0-BE19-25FF0FA07CB5Q39903491-85E03920-BF14-45EA-AFC7-D9A862390D77Q42244370-3D0B0B3B-CD9A-4C08-BC84-A0651CC63538Q42277578-3C0B76EC-01EC-4CC8-96DD-40E99B1BC228Q42374922-F00D4FFD-DC14-4ADB-8331-999FA2B91864Q43147458-C6CA5E70-55C3-442B-906A-2C8CA390898AQ44457497-10E92ADE-C2F4-42DA-BED3-59008E70A454Q53064323-ED26E453-D26B-45F8-9E76-722F92B130EDQ53092142-C218943E-E228-4350-9389-A6D87E6994ABQ53471678-C563F03A-FF6C-4012-8F46-B1FAA6B27373Q59072375-EB45A1B3-EC7C-4725-98A8-2995974A5BD0
P2860
Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Selective growth, in vitro and ...... d from patients with melanoma.
@ast
Selective growth, in vitro and ...... d from patients with melanoma.
@en
type
label
Selective growth, in vitro and ...... d from patients with melanoma.
@ast
Selective growth, in vitro and ...... d from patients with melanoma.
@en
prefLabel
Selective growth, in vitro and ...... d from patients with melanoma.
@ast
Selective growth, in vitro and ...... d from patients with melanoma.
@en
P2093
P2860
P1476
Selective growth, in vitro and ...... d from patients with melanoma.
@en
P2093
Juhua Zhou
Mark E Dudley
Paul F Robbins
Steven A Rosenberg
P2860
P304
P356
10.4049/JIMMUNOL.173.12.7622
P407
P577
2004-12-01T00:00:00Z